Clinical Trial Update: Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of nab-paclitaxel and carboplatin with concurrent radiation therapy for unresectable stage III non-small cell lung cancer was terminated; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-06-09